J. Long

Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.

L. Versea, J. Long, 2006, Seminars in oncology nursing.

Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration.

P. Stephens, V. Miller, G. Frampton, 2017, The oncologist.

Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

M. Badillo, Gretchen A. McNally, L. Brophy, 2015, Journal of the advanced practitioner in oncology.

Treatment approaches and nursing applications for non-Hodgkin lymphoma.

J. Long, 2007, Clinical journal of oncology nursing.

era of novel targeted therapies . Treatment Approaches and Nursing Applications for Non-Hodgkin Lymphoma

J. Long, 2007 .

Potential treatment of hypoparathyroidism with recombinant plasmids encoding preproparathyroid hormone

D. Liu, C. Yang, Y. Zhu, 2012, Journal of Endocrinological Investigation.

1727. Phase 1b Dose-ranging Study Demonstrates Tolerability and Pharmacokinetics (PK) of Oral Epetraborole at the Predicted Therapeutic Dosage for Mycobacterium avium Complex (MAC) Lung Disease

P. Eckburg, K. Krause, G. Talbot, 2022, Open Forum Infectious Diseases.

Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study

Mohammad Amir Sharif, Amit Goyal, N. Dunne, 2023, Breast Cancer Research and Treatment.